ArticleNanomedicine (London, England)2025

The anti-glypican 1 AT101 antibody as targeting agent to effectively deliver chitosan nanobubbles to glioblastoma cells.

Federica Di Cintio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.